Ask AI
Public Law115th CongressHealth
H.R. 304Became Law

Protecting Patient Access to Emergency Medications Act of 2017

This bill became law

Filed
Comm.
Floor
Both
Law

What it doesSummary public law (Nov 17, 2017)

Protecting Patient Access to Emergency Medications Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

What just happenedNov 17, 2017

Signed by President.

Who’s behind it

Rep. Hudson, Richard [R-NC-8](R-NC)Sponsor
25 cosponsors13 D12 R
Read on Congress.gov
25cosponsors3committees28actions1amendments1related bills5subjects
  1. Nov 17, 2017President

    Signed by President.

  2. Nov 17, 2017BecameLaw36000

    Signed by President.

  3. Nov 7, 2017Floor

    Presented to President.

  4. Nov 7, 2017President28000

    Presented to President.

  5. Nov 2, 2017ResolvingDifferencesH41931

    Motion to reconsider laid on the table Agreed to without objection.

  6. Nov 2, 2017ResolvingDifferencesH41610

    On motion that the House agree to the Senate amendment Agreed to without objection. (text as House agreed to Senate Amendment: CR H8421-8422)

  7. Nov 2, 2017NotUsed19500

    Resolving differences -- House actions: On motion that the House agree to the Senate amendment Agreed to without objection.(text as House agreed to Senate Amendment: CR H8421-8422)

  8. Nov 2, 2017FloorH8D000

    Mr. Hudson asked unanimous consent to take from the Speaker's table and agree to the Senate amendment. (consideration: CR H8421-8422)

  9. Oct 25, 2017Floor

    Message on Senate action sent to the House.

  10. Oct 24, 2017Floor

    Passed Senate with an amendment by Unanimous Consent.

  11. Oct 24, 2017Floor17000

    Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.

  12. Oct 24, 2017Floor

    Measure laid before Senate by unanimous consent. (consideration: CR S6773)

  13. Oct 24, 2017Discharge

    Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

    Health, Education, Labor, and Pensions Committee
  14. Oct 24, 2017Committee14500

    Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

    Health, Education, Labor, and Pensions Committee
  15. Jan 12, 2017Committee

    Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

    Crime and Federal Government Surveillance Subcommittee
  16. Jan 10, 2017IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  17. Jan 9, 2017FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  18. Jan 9, 2017FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 404 - 0 (Roll no. 25). (text: CR H206-207)

  19. Jan 9, 2017Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 404 - 0 (Roll no. 25).(text: CR H206-207)

  20. Jan 9, 2017FloorH30000

    Considered as unfinished business. (consideration: CR H218)

  21. Jan 9, 2017FloorH37220

    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

  22. Jan 9, 2017FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 304.

  23. Jan 9, 2017FloorH30000

    Considered under suspension of the rules. (consideration: CR H206-208)

  24. Jan 9, 2017FloorH30300

    Mr. Burgess moved to suspend the rules and pass the bill.

  25. Jan 5, 2017IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Judiciary Committee
  26. Jan 5, 2017IntroReferralH11100

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Energy and Commerce Committee
  27. Jan 5, 2017IntroReferralIntro-H

    Introduced in House

  28. Jan 5, 2017IntroReferral1000

    Introduced in House

Public LawNov 17, 201749

Protecting Patient Access to Emergency Medications Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

House agreed to Senate amendment without amendmentNov 2, 201770

Protecting Patient Access to Emergency Medications Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

Passed Senate amendedOct 24, 201735

Protecting Patient Access to Emergency Medications Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

Passed House without amendmentJan 9, 201781

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Protecting Patient Access to Emergency Medications Act of 2017

(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

Introduced in HouseJan 5, 2017

Protecting Patient Access to Emergency Medications Act of 2017

This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration (DEA) to register an emergency medical services (EMS) agency to administer controlled substances if the agency submits an application demonstrating that it is authorized to conduct such activity in the state in which the agency practices. The DEA may deny an application if it determines that the registration is inconsistent with the public interest.

An EMS agency may obtain a single registration in each state instead of a separate registration for each location.

A registered EMS agency may deliver, store, and receive controlled substances, subject to specified conditions.

An EMS professional of a registered EMS agency may administer controlled substances in schedules II, III, IV, or V outside the physical presence of a medical director if such administration is authorized under state law and pursuant to a standing or verbal order, subject to specified conditions.

The bill specifies that a hospital-based EMS agency (i.e., an EMS agency owned or operated by a hospital) may continue to administer controlled substances under the hospital's DEA registration.

Protecting Patient Access to Emergency Medications Act of 2017 — Informed